ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Ear, nose and throat · Head Neck · 2026-10-05

Meta-analysis of 8 randomised and observational studies (1044 patients) in head and neck SCC: no significant difference between cisplatin- and carboplatin-based regimens in OS, PFS, LRRFS, DMFS or grade ≥3 toxicity; 5-year LRRFS modestly favoured cisplatin (2 studies).

Meta-analysisn = 1,044
Rahim et al. Efficacy and Safety of Cisplatin Versus Carboplatin for Patients With Squamous Cell Carcinoma of Head and Neck: A Systematic Review and Meta-Analysis
Ear, nose and throat · Head Neck · 2026-09-11

Systematic review of 9 studies (8 meta-analysed, 2519 patients) after transoral robotic surgery: bleeding occurred in 8.31% on NSAID regimens, with no significant rise in risk vs no NSAIDs (RR 1.56, p=0.18); NSAIDs were associated with lower 72-h pain and opioid use.

Meta-analysisn = 2,519
Patel et al. Safety and Analgesic Outcomes of Nonsteroidal Anti-Inflammatory Drug-Containing Regimens After Transoral Robotic Surgery: A Systematic Review and Meta-Analysis
Ear, nose and throat · JAMA Otolaryngol Head Neck Surg · 2026-09-01

Secondary analysis of the NDURE trial (145 adults with locally advanced head and neck squamous cell carcinoma): completing over half of care steps mediated 53% and timely postoperative radiation oncology review 24% of the navigation effect on timely PORT versus usual care.

Secondary analysisn = 145
Elhage et al. Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.